Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma

Table 1 The relationship between long noncoding RNA W42 expression and clinicopathological features in hepatocellular carcinoma patients

Parameters	Group	Total	W42 expression		P value
			Low	High
Gender	Male	72	35	37	0.810
	Female	20	11	9
Age (yr)	< 60	27	15	12	0.681
	≥ 60	65	31	34
Tumor size (cm)	< 5	52	25	27	0.846
	≥ 5	40	21	19
AFP	< 20	27	11	16	0.411
	≥ 20	65	35	30
Histological grade	Well/moderately	14	8	6	0.776
	Poorly	78	38	40
Clinical stage	I and II	69	31	38	0.182
	III	23	15	8
Tumor number	Solitary	69	49	20	0.009b
	Multiple	23	6	17
Drinking status	Yes	34	19	23	0.999
	No	58	31	27
Smoking status	Yes	48	22	26	0.563
	No	44	24	20
HBV	Yes	66	30	36	0.419
	No	26	14	12
Recurrence	Yes	29	9	20	0.016a
	No	79	49	30
PVTT	Yes	42	22	20	0.847
	No	50	24	26
Microvascular invasion	Yes	73	37	35	0.999
	No	19	9	10
Liver cirrhosis	Absence	45	16	29	0.030a
	Presence	47	30	17

^aP < 0.05.

^bP < 0.01. AFP: α-Fetoprotein; HBV: Hepatitis B virus; PVTT: Portal vein tumor thrombosis.